saframycin a has been researched along with nadp in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koketsu, K; Oguri, H; Oikawa, H; Suda, H; Watanabe, K | 1 |
| Jiang, CC; Pu, JY; Shi, T; Tang, GL; Tang, MC; Wen, WH; Wu, L; Yu, Q; Zhang, Y; Zhang, YY; Zhao, YL; Zhou, J | 1 |
2 other study(ies) available for saframycin a and nadp
| Article | Year |
|---|---|
Reconstruction of the saframycin core scaffold defines dual Pictet-Spengler mechanisms.
Topics: Antibiotics, Antineoplastic; Cloning, Molecular; Coenzyme A; Deuterium; Escherichia coli; Fatty Acids; Isoquinolines; Kinetics; Models, Molecular; NADP; Streptomyces | 2010 |
Reductive inactivation of the hemiaminal pharmacophore for resistance against tetrahydroisoquinoline antibiotics.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Proteins; Biocatalysis; Biosynthetic Pathways; Chromatography, High Pressure Liquid; Drug Resistance, Microbial; Humans; Isoquinolines; Mass Spectrometry; Molecular Dynamics Simulation; Molecular Structure; NADP; Naphthyridines; Oxidation-Reduction; Oxidoreductases; Tetrahydroisoquinolines | 2021 |